PROVIDENCE, R.I. – Norman Prince Neurosciences Institute and the Lifespan Cancer Institute are thrilled to announce the addition of Dr. Clark Chen, M.D., Ph.D., as the Director of the Brain Tumor Program.
Dr. Chen earned a medical degree and doctoral degree in genetics, both from Harvard Medical School. He completed a clinical fellowship in stereotactic neurosurgery at Beth Israel Deaconess Medical Center and clinical fellowship in radiosurgery at Massachusetts General Hospital. His earlier neurosurgical training included the completion of an internship in surgery and residency in neurosurgery, also at Massachusetts General Hospital, with a post-doctoral fellowship at Dana Farber Cancer Institute.
"In our pursuit of excellence, the Norman Prince Neurosciences Institute continues to elevate its standards. Dr. Chen's remarkable expertise and dedication fortify our team, ensuring unparalleled care for our patients, setting a new benchmark in the region," affirmed Ziya L. Gokaslan, MD, Neurosurgeon-in-Chief at Rhode Island Hospital and The Miriam Hospital.
In his nearly two decades of neurosurgery practice in prominent academic institutions, Dr. Chen rose through the ranks and chaired the Department of Neurosurgery at the University of Minnesota before joining Lifespan. In his new role, Dr. Chen will serve as the Director of the Brain Tumor Program within the Department of Neurosurgery at the Warren Alpert School of Medicine, Brown University as well as, the Co-Director of the Stereotactic Radiosurgery Program. Dr. Chen is an NIH RO1-funded investigator whose research focuses on developing novel diagnostic and therapeutic approaches for brain tumor patients through DNA repair modulation and gene therapy.
“It is our pleasure to welcome Dr. Chen, an internationally recognized neurosurgeon who specializes in the surgical treatments of brain tumors, to the multi-disciplinary team at the Lifespan Cancer Institute. With Dr. Chen's expertise and dedication, we are poised to advance our mission of providing exceptional care and groundbreaking research in the fight against cancer” Stated Dr. David E. Wazer, MD, Oncologist-in-Chief, Radiation Oncology at Rhode Island Hospital and The Miriam Hospital.
Dr. Chen has published over 300 peer-reviewed manuscripts and is consistently recognized with awards, honors, and prizes by national and international organizations for his outstanding administrative leadership, innovative clinical care, and research excellence.
"I am honored to be joining the distinguished ranks of the Norman Prince Neurosciences Institute and Lifespan Cancer Institute. I look forward to collaborating with a multi-disciplinary team, dedicating ourselves to patient-centric care in the realm of glioblastomas and brain tumor treatment. My unwavering commitment is to elevate patient care by intertwining brain tumor research and pioneering clinical trials at Lifespan, extending our impact from Rhode Island to broader horizons," expressed Dr. Clark Chen.
Norman Prince Neurosciences Institute and the Lifespan Cancer Institute welcomes Dr. Chen and looks forward to the exceptional contributions he will make to the study of glioma therapies. His arrival marks a significant step in both institutes mission to continuously advance and provide unparalleled care to patients in the Ocean State and beyond.